Trial Outcomes & Findings for Impact of Skin to Skin Contact on Maternal Satisfaction, Pain Scores, and Narcotic Usage After Cesarean Delivery (NCT NCT02533167)
NCT ID: NCT02533167
Last Updated: 2018-09-05
Results Overview
maternal evoked pain is evaluated utilizing a 100 mm Sliding VAS scale with 0=no pain through 100=most severe pain ever
COMPLETED
NA
70 participants
up to 24 hours
2018-09-05
Participant Flow
Subjects were approached in the preoperative holding room area regarding participation in this study. Subjects were electively scheduled to have a cesarean delivery with proposed healthy outcomes with term deliveries.
Participant milestones
| Measure |
Skin to Skin
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Overall Study
STARTED
|
70
|
|
Overall Study
COMPLETED
|
55
|
|
Overall Study
NOT COMPLETED
|
15
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Impact of Skin to Skin Contact on Maternal Satisfaction, Pain Scores, and Narcotic Usage After Cesarean Delivery
Baseline characteristics by cohort
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
55 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
55 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
55 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 24 hoursmaternal evoked pain is evaluated utilizing a 100 mm Sliding VAS scale with 0=no pain through 100=most severe pain ever
Outcome measures
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Maternal Evoked Pain Scores
|
43.55 units on a scale
Standard Deviation 25.34
|
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 24 hours24 hour morphine equivalents required in the operating room up to the initial 24 hours after delivery for pain management
Outcome measures
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Morphine Usage
|
21.83 mg of morphine
Standard Deviation 19.78
|
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 24 hoursmaternal satisfaction with anesthesia care will be evaluated on post delivery day 1 utilizing a 100mm sliding scale where VAS 0= not satisfied at all up to 100= extremely satisfied
Outcome measures
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Maternal Satisfaction With Anesthesia Care
|
95.91 units on a scale
Standard Deviation 8.19
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 hourswith pain control in the operating room will be evaluated on post delivery day 1 utilizing a 100mm sliding scale VAS 0= not satisfied at all up to 100= extremely satisfied
Outcome measures
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Maternal Satisfaction With Pain Control in the Operating Room
|
94.93 units on a scale
Standard Deviation 15.52
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 hourswith pain control at 24 hours postoperative will be evaluated on post delivery day 1 utilizing a 100mm sliding scale VAS 0= not satisfied at all up to 100= extremely satisfied
Outcome measures
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Maternal Satisfaction With Postoperative Pain Control
|
81.52 units on a scale
Standard Deviation 23.68
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 hoursmaternal satisfaction with operating room atmosphere will be evaluated on post delivery day 1 utilizing a 100mm sliding scale VAS 0= not satisfied at all up to 100= extremely satisfied
Outcome measures
| Measure |
Skin to Skin
n=55 Participants
skin to skin initiated on all consented CS while in the operating room
skin to skin: initiating skin to skin is not currently the standard of care at our facility so there is 1 interventional arm for this study. control group of no skin to skin until recovery room already established as is the standard of care.
|
|---|---|
|
Maternal Satisfaction-operating Room
|
95.98 units on a scale
Standard Deviation 8.94
|
Adverse Events
Skin to Skin
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place